Boceprevir
Boceprevir is a topic covered in the Johns Hopkins HIV Guide.
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Boceprevir is indicated for the treatment of HCV (genotype1, used in combination with peg-INF + ribavirin) in adult patients with compensated liver disease, including cirrhosis.
- Boceprevir may be used in either treatment-naïve patients or those who have failed previously interferon/ribavirin therapy.
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: March 4, 2018
Citation
Smith, Janessa, and Paul A Pham. "Boceprevir." Johns Hopkins HIV Guide, 2018. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545232/all/Boceprevir.
Smith J, Pham PA. Boceprevir. Johns Hopkins HIV Guide. 2018. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545232/all/Boceprevir. Accessed September 21, 2019.
Smith, J., & Pham, P. A. (2018). Boceprevir. In Johns Hopkins HIV Guide. Available from https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545232/all/Boceprevir
Smith J, Pham PA. Boceprevir [Internet]. In: Johns Hopkins HIV Guide. ; 2018. [cited 2019 September 21]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545232/all/Boceprevir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Boceprevir
ID - 545232
A1 - Smith,Janessa,Pharm.D. BCPS
AU - Pham,Paul,PharmD
Y1 - 2018/03/04/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545232/all/Boceprevir
DB - Johns Hopkins Guide
DP - Unbound Medicine
ER -